ProChem Reacts for COVID

In our continued efforts to help with the fight against COVID-19, ProChem Inc. has ramped up production of a critical component in the manufacturing process for the FDA approved use of Remdesivir or Veklury. This is used for patients who are hospitalized due to COVID-19. Studies show that this helps reduce the symptoms and time spent by patients in the hospital. Our company has ramped up production so that the supply of this drug will be able to reach the current demand all over the world. We are excited that we were able to produce this material with the specifications and amounts needed. We reacted quickly to increase our production capabilities so that when they attained the FDA approval it would be able to roll out to hospitals all across the nation as soon as possible.